AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

The article provides an overview of recent developments in the healthcare sector, including Novo Nordisk's phase-out of ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...

Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, confirming an ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...